Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Healogics Newest Service Line Drives Competitive Advantage with Data

Healogics Research Servicessm Provides Comprehensive Market and Clinical Analytics That Enable Access to the Largest Database of Wounded Patients in the World

Related Posts
1 of 29,489

Healogics, the nation’s largest provider of advanced chronic wound care services, announced the debut of their newest service: Healogics Research Services. With robust clinical data on treatments and outcomes of over 1.8 million patients with 5.2 million wounds, Healogics has the largest repository of wound care-specific clinical encounter data in the industry. This data enables Healogics Research Services to generate real world insights that drive patient outcomes, product effectiveness and appropriate utilization.

“With our nationwide network of nearly 700 Wound Care Centers, we care for more than 330,000 patients living with non-healing wounds each year,” said David Bassin, Chief Executive Officer at Healogics. “These numbers translate into meaningful data that enables us to better reach and improve healing for more people living with chronic wounds. We are excited about the unlimited opportunities and insights this new service offers us, our partners and, most importantly, our industry.”

Read More: Interview with Jesse Wolfersberger, Chief Data Officer at Maritz Motivation Solutions

As a division of Healogics, the Research Services team analyzes comprehensive patient level data to guide population identification, aid in study protocol development and identify patients for potential enrollment in late phase studies. Healogics team of experts will augment existing wound care data with broader healthcare, demographic and claims data including indices such as health care accessibility, barriers and patient mix.

“Our Center network is optimized for rapid data collection for the generation of real-world evidence and prospective late-phase studies including product safety, comparative product effectiveness and health economics,” said Dr. Hanna Gordon, PhD, Healogics Executive Director of Research and Informatics. “By partnering with your team, we bring real-world and commercial insights into your clinical development planning process so that you can make more informed, cost-effective decisions.”

Read More: Interview with Yoav Degani, Founder and CEO, VoiceSense

Payers can utilize Healogics data and experience to integrate their claims to develop machine learning models that predict wound patient costs and outcomes, as well as help manage utilization and the patient experience to drive faster heal rates.

Research Services utilizes HIPAA compliant, deidentified data on:

  • Wound treatments and product use
  • Patient outcomes
  • Advanced wound therapies
  • Comorbid conditions
  • Wound etiology and severity
  • Patient characteristics
  • Socio-geographic market demographics
  • Claims based cost and utilization data
  • Provider demographics

Read More: Jumpstart 2019: Interview with Rich Kahn, CEO and Co-Founder, Anura

Leave A Reply

Your email address will not be published.